{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:44Z","timestamp":1793235104516,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In malaria, anti-parasite immune response of the host may lead to dysregulated inflammation causing severe neuropathology arising from extensive damage to the Blood Brain Barrier (BBB). Use of anti-malarial drugs alone can control parasitemia and reduce inflammation but it cannot reduce pathology if chronic inflammation has already set in. In the present study, we have tested the efficacy of a new oral artemsinin based combination therapy (ACT) regimen using a combination of anti-malarial compounds like nanoartemisinin and nanoallylated-chalcone9 [{1-(4-Chlorophenyl)-3-[3-methoxy-4-(prop-2-en-1-yloxy) phenyl]-prop-2-en-1-one}]given together with anti-inflammatory-cum- anti-malarial compounds like nanoandrographolide and nanocurcumin to C57BL\/6 mice infected with <jats:italic>P. berghei<\/jats:italic> ANKA. Untreated infected mice developed Experimental Cerebral Malaria (ECM) and died between 10 to 12 days after infection from severe BBB damage. We observed that oral treatments with nanoartemisinin or nano allylated chalcone 9 or nanoandrographolide alone, for 4 days after the onset of ECM, delayed the development of severe neurolopathology but could not prevent it. Nanocurcumin treatment for 4 days on the other hand, prevented damage to the BBB but the mice died because of hyperparasitemia. A single time oral administration of our ACT controlled blood parasitemia and prevented damage to the BBB, but recrudescence occurred due to persistence of parasites in the spleen. However the recrudescent parasites failed to induce ECM and BBB damage, leading to prolonged survival of the animals. A second time treatment at the start of recrudescence led to complete parasite clearance and survival of mice without pathology or parasitemia for 90 days. FACS analysis of spleen cells and gene expression profile in brain and spleen as well as quantitation of serum cytokine by ELISA showed that <jats:italic>P. berghei<\/jats:italic> ANKA infection in C57Bl\/6 mice leads to a Th1-skewed immune response that result in severe inflammation and early death from ECM. Oral treatment with our ACT prevented a heightened pro-inflammatory response by modulating the Th1, Th2 and Treg immune responses and prevented ECM and death.<\/jats:p>","DOI":"10.3389\/fimmu.2021.819469","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T09:31:02Z","timestamp":1675675862000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of P. berghei ANKA Infected C57BL\/6 Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Sitabja","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopesh","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","unstructured":"World Malaria Report2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/415673a","article-title":"The Pathogenic Basis of Malaria","volume":"415","author":"Miller","year":"2002","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.1999.00188.x","article-title":"Evidence of Blood-Brain Barrier Dysfunction in Human Cerebral Malaria","volume":"25","author":"Brown","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri1686","article-title":"Immunological Processes in Malaria Pathogenesis","volume":"5","author":"Schofield","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2020.11.069","article-title":"Botanical Candidates From Saudi Arabian Flora as Potential Therapeutics for Plasmodium Infection","volume":"28","author":"Al-Quraishy","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2020.12.014","article-title":"Medicinal Plants as a Fight Against Murine Blood-Stage Malaria","volume":"28","author":"Dkhil","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-Resistant Plasmodium Falciparum Malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(01)00140-1","article-title":"Artemisinin and its Derivatives: An Important New Class of Antimalarial Agents","volume":"90","author":"Balint","year":"2001","journal-title":"Pharmacol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.3390\/molecules24193601","article-title":"Combination Therapy Strategies for the Treatment of Malaria","volume":"24","author":"Alven","year":"2019","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-0845","article-title":"Artemisinin Resistance Outside of Southeast Asia","volume":"99","author":"Rosenthal","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1403340","article-title":"The Origins of Antimalarial-Drug Resistance","volume":"371","author":"Packard","year":"2014","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2004.08.006","article-title":"The Origins of Antimalarial Drug Resistance","volume":"20","author":"Hastings","year":"2004","journal-title":"Trends Parasitol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00819.x","article-title":"History and Importance of Antimalarial Drug Resistance","volume":"6","author":"D\u2019Alessandro","year":"2001","journal-title":"Trop Med Int Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of Artemisinin-Resistant Plasmodium Falciparum Malaria in Eastern India","volume":"379","author":"Das","year":"2018","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuv046","article-title":"The Immunological Balance Between Host and Parasite in Malaria","volume":"40","author":"Deroost","year":"2016","journal-title":"FEMS Microbiol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.immunol.23.021704.115638","article-title":"Development and Regulation of Cell-Mediated Immune Responses to the Blood Stages of Malaria: Implications for Vaccine Research","volume":"23","author":"Good","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2006.02.009","article-title":"Conventional and Experimental Treatment of Cerebral Malaria","volume":"36","author":"Golenser","year":"2006","journal-title":"Int J Parasitol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin Action and Resistance in Plasmodium Falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.03.079","article-title":"Design, Economical Synthesis and Antiplasmodial Evaluation of Vanillin Derived Allylated Chalcones and Their Marked Synergism With Artemisinin Against Chloroquine Resistant Strains of Plasmodium Falciparum","volume":"79","author":"Sharma","year":"2014","journal-title":"Eur J Med Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"579518","DOI":"10.1155\/2011\/579518","article-title":"Andrographolide: A Novel Antimalarial Diterpene Lactone Compound From Andrographis Paniculata and Its Interaction With Curcumin and Artesunate","volume":"2011","author":"Mishra","year":"2011","journal-title":"J Trop Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2011.05.009","article-title":"Oral Delivery of Curcumin Bound to Chitosan Nanoparticles Cured Plasmodium Yoelii Infected Mice","volume":"30","author":"Akhtar","year":"2012","journal-title":"Biotechnol Adv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e57302","DOI":"10.1371\/journal.pone.0057302","article-title":"Cellular Effects of Curcumin on Plasmodium Falciparum Include Disruption of Microtubules","volume":"8","author":"Chakrabarti","year":"2013","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1859-1860.2006","article-title":"Curcumin-Artemisinin Combination Therapy for Malaria","volume":"50","author":"Nandakumar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2010.01.005","article-title":"Modulation of Cerebral Malaria by Fasudil and Other Immune-Modifying Compounds","volume":"125","author":"Waknine-Grinberg","year":"2010","journal-title":"Exp Parasitol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00739","article-title":"Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection With Mycobacterium Tuberculosis Following Isoniazid Therapy","volume":"8","author":"Tousif","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-481-4_23","article-title":"Plasmodium Berghei ANKA (PbA) Infection of C57BL\/6J Mice: A Model of Severe Malaria","volume":"1031","author":"de Oca","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.actatropica.2017.04.025","article-title":"Expression of Negative Immune Regulatory Molecules, Pro-Inflammatory Chemokine and Cytokines in Immunopathology of ECM Developing Mice","volume":"172","author":"Khandare","year":"2017","journal-title":"Acta Trop"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00248","article-title":"Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8+ T Cell Responses","volume":"10","author":"Shaw","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-009-1435-8","article-title":"CD4(+) T Cell Response in Early Erythrocytic Stage Malaria: Plasmodium Berghei Infection in BALB\/c and C57BL\/6 Mice","volume":"105","author":"Shibui","year":"2009","journal-title":"Parasitol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02174.x","article-title":"The War Between the Malaria Parasite and the Immune System: Immunity, Immunoregulation and Immunopathology","volume":"133","author":"Artavanis-Tsakonas","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-29967-X_4","article-title":"Experimental Models of Cerebral Malaria","volume":"297","author":"Engwerda","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.9.4093-4099.1998","article-title":"Cloned Lines of Plasmodium Berghei ANKA Differ in Their Abilities to Induce Experimental Cerebral Malaria","volume":"66","author":"Amani","year":"1998","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1801737115","article-title":"Targeting the IL33-NLRP3 Axis Improves Therapy for Experimental Cerebral Malaria","volume":"115","author":"Strangward","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone Effective Against Murine Cerebral Malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181eee738","article-title":"Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome","volume":"68","author":"Idro","year":"2010","journal-title":"Pediatr Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.051","article-title":"Curcumin for Malaria Therapy","volume":"326","author":"Reddy","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1038\/s41598-017-10672-9","article-title":"Nanocurcumin is Superior to Native Curcumin in Preventing Degenerative Changes in Experimental Cerebral Malaria","volume":"7","author":"Dende","year":"2017","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.1038\/srep12671","article-title":"Simultaneously Targeting Inflammatory Response and Parasite Sequestration in Brain to Treat Experimental Cerebral Malaria","volume":"5","author":"Dende","year":"2015","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic Roles of Curcumin: Lessons Learned From Clinical Trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1416","article-title":"Antimalarial Drug Discovery: Efficacy Models for Compound Screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2875-8-26","article-title":"Anti-Malarial Activities of Andrographis Paniculata and Hedyotis Corymbosa Extracts and Their Combination With Curcumin","volume":"8","author":"Mishra","year":"2009","journal-title":"Malar J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and Artemisinin Plus Curcumin Liposomal Formulations: Enhanced Antimalarial Efficacy Against Plasmodium Berghei-Infected Mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1086\/514129","article-title":"The Novel Oxygenated Chalcone, 2,4-Dimethoxy-4\u2019-Butoxychalcone, Exhibits Potent Activity Against Human Malaria Parasite Plasmodium Falciparum In Vitro and Rodent Parasites Plasmodium Berghei and Plasmodium Yoelii In Vivo","volume":"176","author":"Chen","year":"1997","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000322532","article-title":"In Vitro Biotransformation, In Vivo Efficacy and Pharmacokinetics of Antimalarial Chalcones","volume":"87","author":"Gutteridge","year":"2011","journal-title":"Pharmacology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s41467-018-04108-9","article-title":"A Cryptic Cycle in Haematopoietic Niches Promotes Initiation of Malaria Transmission and Evasion of Chemotherapy","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pim.12005","article-title":"Splenocyte Apoptosis in Plasmodium Berghei ANKA Infection: Possible Role of TNF-\u03b1 and TGF-\u03b2","volume":"35","author":"Keswani","year":"2013","journal-title":"Parasite Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01636-09","article-title":"Increased Tolerance to Artemisinin in Plasmodium Falciparum Is Mediated by a Quiescence Mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1086\/656476","article-title":"Artemisinin-Induced Dormancy in Plasmodium Falciparum: Duration, Recovery Rates, and Implications in Treatment Failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1471-2164-12-391","article-title":"Artemisinin Resistance in Plasmodium Falciparum Is Associated With an Altered Temporal Pattern of Transcription","volume":"12","author":"Mok","year":"2011","journal-title":"BMC Genomics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300396","article-title":"The Transcription Factor T-Bet Regulates Parasitemia and Promotes Pathogenesis During Plasmodium Berghei ANKA Murine Malaria","volume":"191","author":"Oakley","year":"2013","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/ni.2059","article-title":"T-Bet in Disease","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01783-06","article-title":"CD4+ CD25+ Regulatory T Cells Suppress CD4+ T-Cell Function and Inhibit the Development of Plasmodium Berghei-Specific TH1 Responses Involved in Cerebral Malaria Pathogenesis","volume":"75","author":"Nie","year":"2007","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00324","article-title":"Cytokines and Chemokines in Cerebral Malaria Pathogenesis","volume":"7","author":"Dunst","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000779","article-title":"IL-4 Treatment Mitigates Experimental Cerebral Malaria by Reducing Parasitemia, Dampening Inflammation, and Lessening the Cytotoxicity of T Cells","volume":"206","author":"Wu","year":"2021","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: The Master Regulator of Immunity to Infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00290.x","article-title":"Interleukin-10 Modulates Susceptibility in Experimental Cerebral Malaria","volume":"91","author":"Kossodo","year":"1997","journal-title":"Immunology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12936-021-03888-8","article-title":"Combining Malaria Vaccination With Chemoprevention: A Promising New Approach to Malaria Control","volume":"20","author":"Greenwood","year":"2021","journal-title":"Malar J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.819469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T09:31:06Z","timestamp":1675675866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.819469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2021.819469"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.819469","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"819469"}}